Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial

D Watson-Jones, HA Weiss, M Rusizoka… - JAIDS Journal of …, 2007 - journals.lww.com
D Watson-Jones, HA Weiss, M Rusizoka, K Baisley, K Mugeye, J Changalucha, D Everett
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007journals.lww.com
Objectives: To determine prevalence of and risk factors for herpes simplex virus type 2 (HSV-
2) and HIV among women being screened for a randomized, controlled trial of HSV
suppressive therapy in northwestern Tanzania. Methods: Two thousand seven hundred
nineteen female facility workers aged 16 to 35 were interviewed and underwent serological
testing for HIV and HSV-2. Factors associated with HSV-2 and HIV in women aged 16 to 24
were examined using logistic regression to estimate odds ratios (OR) and 95% confidence …
Abstract
Objectives:
To determine prevalence of and risk factors for herpes simplex virus type 2 (HSV-2) and HIV among women being screened for a randomized, controlled trial of HSV suppressive therapy in northwestern Tanzania.
Methods:
Two thousand seven hundred nineteen female facility workers aged 16 to 35 were interviewed and underwent serological testing for HIV and HSV-2. Factors associated with HSV-2 and HIV in women aged 16 to 24 were examined using logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI).
Results:
HSV-2 seroprevalence was 80%, and HIV seroprevalence was 30%. Among women aged 16 to 24, both infections were significantly and independently associated with older age, being a bar worker, working at a truck stop, and having more lifetime sexual partners. HSV-2 infection was also associated with lower socioeconomic status, increased alcohol intake, younger age at first sex, inconsistent condom use, and vaginal douching. There was a strong association between the 2 infections after adjustment for other factors (OR= 4.22, 95% CI: 2.6 to 6.9).
Conclusions:
Female facility workers in northwestern Tanzania are vulnerable to HSV-2 and HIV infections. Programs designed to increase safer sexual behavior and reduce alcohol use could be effective in reducing HSV-2 incidence and, in turn, HIV infection. This is a suitable population for an HSV suppressive therapy trial.
Lippincott Williams & Wilkins